Neni Susilaningsih

No ORCID on file · 4 papers in corpus · active 2025-2026

Study types

  • article 3
  • other 1

Condition tags

  • endometriosis 4
  • dysmenorrhea 1
  • die_deep_infiltrating 1
  • adenomyosis 1
  • dyspareunia 1
other 2026
The inhibition of deep peritoneal endometriosis by Andrographolide through macrophage M1 activity in an endometriosis mice model
Veterinarni medicina ·doi:10.17221/32/2025-VETMED

This study aims to demonstrate that Andrographolide, an herbal immunostimulant, can influence M1 macrophages to inhibit inflammation, including the growth of endometriosis caused by inflammation. This study evaluates the effects of Androgra…

article 2025
Dienogest Therapy Against the Combined Oral Contraceptive Pill in Deep Infiltrating Endometriosis Cases: A Systematic Review and Meta-Analysis
·doi:10.4103/gmit.gmit-d-24-00021

Abstract Objectives: Deep endometriosis (DE) is a common disease in 15%–45% of childbearing-age women. Combined oral contraceptive pill (COCP) and dienogest have been used for decades to treat many forms of endometriosis after laparoscopy s…

article 2025
Inguinal Lump, Please Put an Endometriosis Extra Pelvic on Your Diagnosis List : Cases Series of Deep Endometriosis
·doi:10.47836/mjmhs.21.4.50

Deep Endometriosis is usually found in the ovaries, peritoneum, gynecological organs and in the pouch of Douglas. We have reported 5 rare cases of extra-pelvic endometriosis from 2018-2023 on a patient who had endometriosis surgery and suff…

article 2025
Changes in the M1/M2 ratio due to andrographolide therapy for deep endometriosis: An experimental study using a BALB/C endometriosis model
Open veterinary journal ·doi:10.5455/ovj.2025.v15.i6.57

Background: Andrographolide is a compound that serves as an anti-inflammatory agent. M2 macrophages promote the disease, while M1 macrophages inhibit endometriosis progression. Aim: Andrographolide can modify the M1/M2 ratio, aligning with …